ClinicalTrials.Veeva

Menu

Astigmatism in Keratoconus Patients

A

Assiut University

Status

Unknown

Conditions

Keratoconus

Treatments

Device: Pentacam

Study type

Interventional

Funder types

Other

Identifiers

NCT03450213
Keratoconus

Details and patient eligibility

About

Keratoconus is a bilateral (but usually asymmetrical) non-inflammatory progressive thinning process of the cornea. It manifests as characteristic cone-like ectasia of the cornea associated with irregular stromal thinning, resulting in a cone-like bulge , which causing irregular astigmatism and vision impairment.

Full description

Keratoconus is the most common form of corneal ectasia, with an incidence of 50-230 per 100,000 persons.Pentacam used diagnose & detect the progression in patients with keratoconus and also provide a detailed information about corneal tomography and topography.

In the last few years, it has been shown that in healthy individuals the posterior corneal surface has not only a different amount of astigmatism but also a different alignment of the steep meridian.

The aim of this research is to compare the amount and axis alignment of anterior and posterior corneal astigmatism in keratoconus with a healthy controlled group .

Enrollment

100 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with keratoconus using the following criteria:

Specific diagnostic signs is asymmetric refractive errors with high progressive or irregular astigmatism, and elevated keratometry values, scissoring of the red reflex, Vogt striae, Fleischer rings, inferior or central steepening on topography with abnormal localized steepening .

Exclusion criteria

  • Unwillingness to participate in the study .
  • Corneal scarring.
  • Any ectatic conditions that were not explicitly keratoconus such as keratoglobus and pellucid marginal degeneration .
  • Previous ocular surgery.

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups, including a placebo group

Patients with keratoconus
Active Comparator group
Description:
Pentacam will be used for comparison between astigmatism in patients with keratoconus and normal people at the same age and sex.
Treatment:
Device: Pentacam
Normal people at the same age and sex
Placebo Comparator group
Description:
Pentacam will be used for comparison between astigmatism in patients with keratoconus and normal people at the same age and sex.
Treatment:
Device: Pentacam

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems